Published in Med Res Rev on May 16, 2016
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82
Mitochondrial membrane permeabilization in cell death. Physiol Rev (2007) 12.72
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol (2003) 6.27
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J (2003) 4.70
Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation (1991) 4.30
The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res (2006) 3.83
Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J (2005) 2.55
International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev (1996) 2.43
Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol Sci (2007) 2.24
Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett (1994) 2.17
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev (2007) 2.14
Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. JACC Cardiovasc Interv (2010) 1.93
Cardioprotection at a distance: mesenteric artery occlusion protects the myocardium via an opioid sensitive mechanism. J Mol Cell Cardiol (2002) 1.87
G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem (2005) 1.82
Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation (2003) 1.80
[3H]U-69593 a highly selective ligand for the opioid kappa receptor. Eur J Pharmacol (1985) 1.77
The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta (2007) 1.74
Postconditioning prevents reperfusion injury by activating delta-opioid receptors. Anesthesiology (2008) 1.71
The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol (2009) 1.66
Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes (2005) 1.62
Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J Biol Chem (2004) 1.62
Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats. Anesth Analg (2009) 1.58
The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta. Am J Physiol Heart Circ Physiol (2006) 1.48
Synthesis and in vitro opioid activity profiles of DALDA analogues. Eur J Med Chem (2000) 1.47
Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res (2001) 1.43
Opioid receptor stimulation acts as mediator of protection in ischaemic preconditioning. Cardiovasc J S Afr (2001) 1.41
Retracted Role of opioid delta1 receptors, mitochondrial K(ATP) channels, and protein kinase C during cardiocyte apoptosis. J Mol Cell Cardiol (2001) 1.41
Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther (1994) 1.36
Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol (1999) 1.33
Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res (1996) 1.24
GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion. Basic Res Cardiol (2007) 1.24
Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia. Br J Pharmacol (1983) 1.21
Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ Res (1999) 1.20
Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore. J Pharmacol Exp Ther (2008) 1.19
Cardiac preconditioning for ischaemia: lost in translation. Dis Model Mech (2010) 1.18
Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol (1997) 1.18
Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes (2007) 1.18
Direct dependence studies in rats with agents selective for different types of opioid receptor. J Pharmacol Exp Ther (1988) 1.17
An intrinsic adrenergic system in mammalian heart. J Clin Invest (1996) 1.17
Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem (1995) 1.14
Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther (2000) 1.11
Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun (1996) 1.11
Remifentanil preconditioning protects against ischemic injury in the intact rat heart. Anesthesiology (2004) 1.09
Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther (2001) 1.09
Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol (2001) 1.09
Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ Res (1999) 1.09
Blood-brain barrier restriction of peptides and the low uptake of enkephalins. Endocrinology (1978) 1.08
Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol (1995) 1.08
Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur J Pharmacol (1990) 1.06
A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol (1995) 1.05
Morphine mimics preconditioning via free radical signals and mitochondrial K(ATP) channels in myocytes. Circulation (2001) 1.05
Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts. J Cardiovasc Pharmacol Ther (2012) 1.04
Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart. Cardiovasc Res (2004) 1.04
Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci (2007) 1.03
Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. Am J Physiol (1994) 1.03
Morphine postconditioning protects against reperfusion injury in the isolated rat hearts. J Surg Res (2007) 1.03
Programmed death as a therapeutic target to reduce myocardial infarction. Trends Pharmacol Sci (2007) 1.02
Remifentanil preconditioning confers delayed cardioprotection in the rat. Br J Anaesth (2007) 1.02
Stereospecific antiarrhythmic effect of opioid receptor antagonists in myocardial ischaemia. Br J Pharmacol (1986) 1.01
Distinct subcellular distribution of delta-opioid receptor fused with various tags in PC12 cells. Neurochem Res (2008) 1.00
Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways. Am J Physiol Heart Circ Physiol (2006) 1.00
TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol (1998) 1.00
Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial. Interact Cardiovasc Thorac Surg (2010) 1.00
Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of delta-opioid receptor. Am J Physiol Heart Circ Physiol (2004) 0.99
Autoradiographic localization of (125)i[Tyr(14)] nociceptin/orphanin FQ binding sites in macaque primate CNS. Neuroscience (2003) 0.99
Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation (1998) 0.99
ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol (2001) 0.99
Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy. Expert Opin Pharmacother (2012) 0.98
Morphine-tolerant mice exhibit a profound and persistent cardioprotective phenotype. Circulation (2004) 0.98
Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am J Physiol Heart Circ Physiol (2001) 0.98
Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival. Eur J Pharmacol (2009) 0.98
The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia. Br J Pharmacol (1989) 0.97
Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation (1996) 0.97
Naloxone blocks transferred preconditioning in isolated rabbit hearts. J Mol Cell Cardiol (2001) 0.96
Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res (1999) 0.96
Left ventricular performance and pulmonary circulation following addition of nitrous oxide to morphine during coronary-artery surgery. Anesthesiology (1975) 0.96
Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts. Basic Res Cardiol (2008) 0.96
Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Basic Res Cardiol (2000) 0.95
Role of kappa-opioid receptor activation in pharmacological preconditioning of swine. Am J Physiol Heart Circ Physiol (2003) 0.95
The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation. Am J Physiol Heart Circ Physiol (2007) 0.94
Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF. J Mol Cell Cardiol (2004) 0.94
Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial. J Cardiothorac Vasc Anesth (2010) 0.94
Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS. Am J Physiol Heart Circ Physiol (2005) 0.94
The kappa opioid receptor: from addiction to depression, and back. Front Psychiatry (2014) 0.94
Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice. Synapse (2006) 0.93
Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels. Am J Physiol Heart Circ Physiol (2003) 0.93
Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.93
Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors. Am J Physiol Heart Circ Physiol (2003) 0.93
The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue. Heart Vessels (2014) 0.92
Remifentanil preconditioning confers cardioprotection via cardiac kappa- and delta-opioid receptors. Anesthesiology (2005) 0.92
Kappa-opioid receptors mediate cardioprotection by remote preconditioning. Anesthesiology (2006) 0.92
Naloxone inhibits arrhythmias induced by coronary artery occlusion and reperfusion in anaesthetized dogs. Br J Pharmacol (1986) 0.92
Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem (1998) 0.92
Reperfusion syndrome: cellular mechanisms of microvascular dysfunction and potential therapeutic strategies. Vasc Endovascular Surg (2007) 0.92
Human studies of cannabinoids and medicinal cannabis. Handb Exp Pharmacol (2005) 0.91
Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion. Anesth Analg (2009) 0.91
Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection. J Mol Cell Cardiol (2007) 0.91
Effects of beta-endorphin on the contraction and electrical activity of the isolated perfused rat heart. Int J Pept Protein Res (1984) 0.91
Cardioprotection following adenosine kinase inhibition in rat hearts. Basic Res Cardiol (2005) 0.91
Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim Biophys Acta (1989) 0.90